Anxo’s 505(b)(2) New Drug for Schizophrenia Receives Taiwan Patent

Anxo’s 505(b)(2) new drug for the treatment of schizophrenia, AX251a, has received Taiwan Invention Patent No. I930440, granted by the Taiwan Intellectual Property Office (TIPO) under the Ministry of Economic Affairs, for its patent application titled “Injectable Depot Formulation of Cariprazine Free Base Particles.”